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Abstract 
Experiments in recent years have revealed labile electrophysiological and neurochemical 
phenotypes in primary afferent neurons exposed to specific stimulus conditions 
associated with the development of chronic pain. These studies collectively demonstrate 
that the mechanisms responsible for functional plasticity are primarily mediated by novel 
neuroimmune interactions involving circulating and resident immune cells and their 
secretory products, which together induce hyperexcitability in the primary sensory 
neurons. In another peripheral sensory modality, namely the arterial chemoreceptors, 
sustained stimulation in the form of chronic hypoxia (CH) elicits increased chemoafferent 
excitability from the mammalian carotid body. Previous studies which focused on 
functional changes in oxygen-sensitive type I cells in this organ have only partially 
elucidated the molecular and cellular mechanisms which initiate and control this adaptive 
response. Recent studies in our laboratory indicate a unique role for the immune system 
in regulating the chemo-adaptive response of the carotid body to physiologically relevant 
levels of hypoxia.  
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 Introduction 
Oxygen chemoreceptors in the carotid body continuously monitor arterial blood PO2 as 
part of a complex autonomic mechanism that matches lung ventilation and cardiac output 
to systemic tissue oxidative metabolism. Acute hypoxia excites oxygen-sensitive type I 
cells in carotid body and elevates impulse traffic in the carotid sinus nerve (CSN) which 
reflexly increases ventilation. Under controlled conditions, CSN responses to repeated 
acute hypoxic challenges are highly reproducible. However, a peculiar aspect of carotid 
body function is that following chronic hypoxia (CH), chemoreceptor activity evoked by 
an acute challenge is substantially enhanced. This increased activity has been shown to 
underlie ventilatory acclimatization to hypoxia (VAH), a phenomenon in mammals 
characterized by a gradual increase in ventilation which occurs over a period of days-to-
weeks at high altitude and in hypobaric hypoxia(Powell, Milsom et al. 1998). The cellular 
and molecular mechanisms underlying CH-induced chemoreceptor adaptation are only 
partially understood. The current review highlights the role of unique neuroimmune 
mechanisms in the adaptive process. Available data suggest that chemoreceptor plasticity 
is analogous to adjustments induced in the peripheral nervous system during chronic 
inflammatory pain. 
 
The Carotid Body and Adaptation to Chronic Hypoxia 
 The carotid body consists of integrated units of chemoreceptor, neural, glial and vascular 
cells surrounded by connective tissue, which collectively constitute a highly adaptive 
chemosensory organ. Stimulus transduction occurs in paracrine type I (chemoreceptor) 
cells which release multiple neuro-active agents in response to hypoxia, hypercapnia and 
acidosis. Primary afferent neurons in the petrosal ganglia (PG) project axons through the 
carotid sinus nerve (CSN) to form synaptic terminals on type I cells, while glial-like type 
II cells envelop the type I cells and terminal axon enlargements, forming lobules which 
are embedded in connective tissue penetrated by a microvascular network of highly 
permeable sinusoidal capillaries. Fibroblasts, resident macrophages, and a small number 
of mast cells are also present in the tissue, together with post-ganglionic parasympathetic 
and sympathetic axons(McDonald ,1981). According to the current view of low O2-
transduction, specialized K+-channels close when ambient O2 decreases, initiating Ca2+ 
entry and excitatory neurotransmitter(s) release by type I cells. This leads to activation of 
chemoafferent neurons projecting to the nucleus tractus solitarius (NTS) of the medulla 
(Buckler ,1999;Gonzalez, Almaraz et al. 1994). 
 
Adaptation to CH involves remarkable morphological and physiological adjustments in 
the rat carotid body, including altered morphology, gene expression and increased 
chemosensitivity in the initial 1-3 days of exposure to hypobaric hypoxia (380 
Torr)(Chen, He et al. 2002a;Chen, He et al. 2002b;Dinger, He et al. 2003).  Such changes 
subsequently include elevated expression of vasoactive agents: vascular endothelial 
growth factor (VEGF), endothelin (ET), atrial natriuretic peptide (ANP) and nitric oxide 
(NO), which contribute to tissue remodeling and/or modified chemosensitivity (Chen, 
He, Dinger, Stensaas, and Fidone et al. ,2002a;Chen, He, Dinger, Stensaas, and Fidone 
,2002b;He, Chen et al. 1998;He, Dinger et al. 2000;Dinger, He, Chen, Stensaas, and 
Fidone ,2003). Moreover, rat type I cells have been shown to increase Na+-channel (NaV 
1.1) expression in CH, an adaptation which may contribute to enhanced cell 
depolarization and neurotransmitter release(Caceres, Obeso et al. 2007).  Adaptive 
changes to CH are also observed in chemoafferent neurons of the PG, which involve the 
expression of cholinergic receptors, and altered purinergic and cholinergic 
chemotransmission between type I cells and chemoafferent neurons (He, Dinger et al. 
2005;He, Chen et al. 2006).  In addition, we have documented elevated expression of the 
gap-junction-forming protein, connexin-43 in type I cells and PG neurons (Chen, He, 
Dinger, Stensaas, and Fidone ,2002b).  
 
Given their exquisite sensitivity to oxygen, it has long been assumed that type I cells 
initiate and regulate adaptive processes via the autocrine and paracrine action of their 
secretory products. Consistent with this assumption, studies of these cells following CH 
have demonstrated phenotypic changes consistent with increased excitability(Bisgard 
,2000;Wang and Bisgard ,2002). However, the alternate possibility that CH-induced 
adaptation involves other cell types in the carotid body has been virtually ignored. 
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Moreover, little consideration has been given to the hypothesis that chemoreceptor 
adaptation is dependent on major changes in the excitability of chemoafferent neurons.  
 
The Chronic Pain Model of Sensory Neuron Adaptation 
Amongst sensory systems, altered sensitivity in response to chronic stimulation is not 
unique to the carotid body. In fact, it has long been known that chronic inflammation or 
neuropathy induces chronic pain states characterized by hyperalgesia and allodynia. 
Within the last decade it has become widely recognized that nociceptor hyperexcitability 
involves unique neuroimmune mechanisms(Watkins and Maier ,2002). Numerous studies 
of chronic pain have demonstrated that invading macrophages and neutrophils, as well as 
resident mast cells and dendritic cells induce remodeling and hypersensitivity of primary 
nociceptor neurons (Watkins and Maier ,2002). In addition, mechanoreceptor neurons 
that do not normally signal pain initiate the production of “pain neurotransmitters” 
consequent to the action of inflammatory mediators (Neumann, Doubell et al. 1996). 
Even cells which are not commonly associated with immune function may participate in 
the alteration of peripheral nerve function. For example, fibroblasts become a source of 
chemoattractant chemokine molecules [e.g., macrophage inflammatory protein-2 (MIP-2) 
and monocyte chemoattractant protein-1 (MCP-1)] that recruit circulating immune cells 
(primarily neutrophils and macrophages); this is followed by the production and secretion 
of proinflammatory cytokines(Watkins and Maier ,2002).  Numerous studies of chronic 
inflammatory and neuropathic pain consistently demonstrate up-regulation of three 
cytokines: interleukin-1β (Il-1β), interleukin-6 (Il-6) and tumor necrosis factor-α (TNF-
α), along with the chemokine, MCP-1(Watkins and Maier ,2002).   
 
The growing body of evidence that supports a connection between immune cells and the 
development of altered tissue structure and hyperexcitability in chronic pain appears to 
provide a model for the role of immune cells and cytokines in altered carotid body 
structure, and the increased chemosensitivity in CH. In an effort to follow this lead we 
have set forth to determine 1), whether CH induces an inflammatory condition in the 
carotid body, 2), the effect of common anti-inflammatory drugs on chemoreceptor 
adaptation, and 3), indications of CH/inflammation-induced phenotypic changes that are 
consistent with increased excitability in chemoafferent PG neurons. 
 
CH-Induced Immune Cell Invasion and Cytokine Expression in Carotid Body 
It is well known that immune cells express an isoform of the enzyme NADPH oxidase 
(Nox2) which uses O2 and the cofactor NADPH to produce reactive oxygen species 
(ROS) as part of a killing mechanism in tissues invaded by infectious microbes. 
Experiments in our laboratory established that Nox2 and Nox4 are increased in carotid 
body in CH(He, Liu et al. 2010). These findings may reflect increased Nox expression by 
resident cells in the organ and/or they may be due to invasion of activated immune cells, 
primarily monocytes and neutrophils. Circulating monocytes commonly differentiate into 
ED1+ macrophages following diapedesis. We used fluorescent immunocytochemistry to 
establish the time-course of ED1+ cell activity in carotid body following 0, 1, 3 and 7 
days of CH @ 380 Torr(Liu, He et al. 2009). Figure 1 shows that ED1+ cells are rare in 
normal carotid body, and that their presence is only slightly increased following 1 day of 
CH. However, following 3 days of CH the population of ED1+ cells is substantially 
elevated. After 7 days the incidence of macrophages remains high, but somewhat less 
than in organs from 3 day CH rats. 
 
The increased presence of immune cells in the carotid body is correlated with elevated 
expression of inflammatory cytokines(Liu, He, Stensaas, Dinger, and Fidone ,2009). 
Quantitative PCR studies (see figure 2) showed that 24 hr of hypoxia elicited a 2-3-fold 
increase in MCP-1, IL-1β and TNFα. The lattermost cytokine remained at similar levels 
following 3 and 7 days of CH, whereas IL-1β was equally elevated following 3 days, but 
fully recovered after 7 days. In contrast the chemoattractant chemokine, MCP-1 was 
further elevated beyond 6-fold after 3 days, and it remained at a similar level on day 7. 
CH induced a more gradual increase in IL-6 which was measured at ~3-fold and ~2-fold 
following 3 and 7 days of CH, respectively. Interestingly, following 28 days of hypoxia 
the expression of inflammatory molecules was normal, with the exception of IL-6 which 
was some 5.5-fold above normal, suggesting that this latter cytokine may play a 
maintenance role in chemoreceptor adaptation. Support for the validity of the qPCR 
assays was provided by assessments of the mRNA transcript level of tyrosine 
hydroxylase (TH), which is known to increase in type I cells during CH (figure 2). 
 
Additional studies in our laboratory showed that cytokine production was not limited to 
immune cells(Liu, He, Stensaas, Dinger, and Fidone ,2009). Indeed, in situ hybridization 
experiments showed that IL-6 expression during CH is increased to high levels in 
putative type II cells, while a smaller but substantial elevation in probe signal was 
localized to cell clusters displaying morphology consistent with type I cells. We also used 
amplified RNA (aRNA) technology to demonstrate that 24 hr of in vivo hypoxia elevated 
MCP-1, IL-1β, TNFα and IL-6 in type I cells isolated in culture. These findings are in 
agreement with Lam et al.(Lam, Tipoe et al. 2008), who used immunocytochemical 
techniques to show elevated expression of inflammatory cytokines in type I cells 
following 7 days of CH. These studies also support the concept that virtually all cells are 
capable of cytokine production(Oppenheim J J and Feldmann M ,2000). 
 
Effect of Anti-Inflammatory Drugs on Chemoreceptor Adaptation 
Studies of inflammatory pain in rats have shown that small doses of the common anti-
inflammatory drugs ibuprofen and dexamethasone prevent phenotypic changes associated 
with hyperexcitability in DRG neurons(O'Rielly and Loomis ,2008;Huang, Hsu et al. 
2010;Voilley, de et al. 2001;Teixeira, Oliveira et al. 2010). Ibuprofen is a well 
established non-selective inhibitor of cyclooxygenase 1 and 2 (COX1 and 
COX2)(Rainsford ,2003). In addition, this drug has been shown to block the nuclear 
translocation of the transcription factor, nuclear factor kappa beta (NF-κβ), which 
mediates cytokine production including IL-1β, TNFα and IL-6(Scheuren, Bang et al. 
1998). A potentially important physical property of ibuprofen is its tendency to partition 
into low pH compartments, such as local areas of inflammation(Brune and Lanz 
,1985;Brune, Graf et al. 1976). The steroid, dexamethasone, operates via nuclear 
receptors to block the cascade of cytokine synthesis and release. Studies have shown that 
dexamethasone blocks the early inflammation-induced release of IL-1β and 
TNFα(Haynes ,1990). IL-6 production is also suppressed at least in part due to its 
dependence on the actions of IL-1β and TNFα(Haynes ,1990). 
 Figure 3 shows the effects of these drugs on hypoxia-evoked chemoreceptor discharge 
recorded in carotid body-CSN preparations superfused in vitro. The upper panel 
demonstrates the effect of CH on carotid body excitability in a side-by-side comparison 
of integrated nerve activity in a normal versus 9-day CH preparation. Following CH, the 
activity evoked by a standardized acute hypoxic stimulus (bath PO2 recorded via separate 
trace) is approximately doubled, as indicated in the summary histogram of 4 preparations. 
The middle and lower panels show the effect of concurrent administration of ibuprofen (4 
mg/kg/day, i.p.) or dexamethasone (0.1 mg/kg/day, i.p.) in non-hypoxic (normal) and CH 
animals. The results indicate that treatment with the anti-inflammatory drugs during CH 
completely blocks chemoreceptor adaptation. 
 
Parallel studies evaluated the effect of these anti-inflammatory drugs on cytokine 
expression in the carotid body. The data in figure 4A indicate that ibuprofen inhibits 
more than 50% of the increase in expression of MCP-1, TNFα and IL-6 induced by 7 
days of CH. As shown in figure 2, IL-1β expression is fully recovered at this time point, 
and the presence of ibuprofen had no significant effect on the expression of this cytokine. 
It is also noteworthy that ibuprofen did not significantly alter CH-induced up-regulation 
of TH mRNA, suggesting that this phenomenon occurs independently of the 
inflammatory response. In contrast, the increase in TH expression was enhanced during 
CH in animals treated with dexamethasone (figure 4B), a finding which concurs with 
previously demonstrated effects of this drug on normal carotid body(Hanbauer ,1976). 
Moreover, this steroid potently blocked expression of all cytokines, even lowering IL-1β 
to a level slightly below normal. 
 
Confirmation of the drug effects on immune cell activity was achieved by evaluating the 
inmmunostaining intensity of immune specific antigen CD45 in carotid body. Virtually 
all immune cells express this antigen which is known to be increased in inflamed tissue. 
The images in figure 5 show that the low CD45 intensity (green) in normal carotid body 
is substantially enhanced in tissue from a 3-day CH rat. Immunostaining for TH (red) is 
also greatly elevated in the CH tissue. Treatment with ibuprofen (4 mg/kg/day) or 
dexamethasone (0.1 mg/kg/day) lowered CD45 expression in normal tissue, and 
eliminated the increase induced by CH. Consistent with qPCR assays, increased 
immunostaining for TH following CH was not altered by ibuprofen, but it appeared to be 
slightly elevated by treatment with dexamethasone in both normal and CH tissue. 
 
Inflammation and Primary Sensory Neuron Excitability 
Numerous studies have shown that inflammation in the terminal fields of peripheral 
nerves induces phenotypic changes in primary sensory neurons, leading to 
enhanced excitability. Behavioral assessments have consistently demonstrated 
lowered mechanical and thermal stimulus thresholds and decreased latencies for 
reflexes elicited from inflamed peripheral fields. These changes have been 
correlated with altered gene and/or protein expression in corresponding DRG 
sensory neurons. Amongst the up-regulated genes are those coding for specialized 
transduction/receptor molecules, including ATP-gated purinergic receptors 
(P2XN)(Barclay, Patel et al. 2002;Jarvis ,2010), acid sensitive ion channels 
(ASICs)(Mamet, Baron et al. 2002;Voilley, de, Mamet, and Lazdunski ,2001), 
and the multimodal transient receptor potential vallinoid-1 (TRPV1) receptor, 
which is sensitive to temperature, pH and selected chemical stimuli(Stucky, 
Dubin et al. 2009). Importantly, pharmacological manipulations which block 
inflammation-induced expression of transducer molecules, also decrease the 
associated hyperalgesia and allodynia(Voilley, de, Mamet, and Lazdunski 
,2001;Barclay, Patel, Dorn, Wotherspoon, Moffatt, Eunson, Abdel'al, Natt, Hall, 
Winter, Bevan, Wishart, Fox, and Ganju ,2002). 
 
In addition to the altered expression of transducer molecules, numerous studies by 
Waxman and his colleagues(Cummins, Sheets et al. 2007) have shown that inflammation 
induces altered expression of selected proteins that comprise voltage-gated Na+-channels 
(VGSC or NaV), which are generally responsible for the rapid up-stroke of the action 
potential in peripheral axons. VGSC consist of α- and β-subunits, with the latter serving a 
supporting role as stabilizers and modulators of α-subunit function. Thus specific channel 
properties, including gating, kinetics and conductance are determined primarily by 9 
isoforms of the α-subunit found in mammals(Cummins, Sheets, and Waxman ,2007). 
Molecular analysis has revealed that primary sensory neurons in DRG express at least 5 
α-subtypes including the tetrodotoxin (TTX)-sensitive NaV1.1, NaV1.6, NaV1.7; and the 
TTX-resistant NaV1.8 and NaV1.9(Waxman, Cummins et al. 2000).  Models of 
neuropathic pain (e.g., peripheral axotomy; nerve constriction) have shown down-
regulation of Nav1.8 and Nav1.9, and the induced expression of a previously silent TTX-
sensitive (TTX-S) channel, NaV1.3(Waxman, Cummins, Dib-Hajj, and Black ,2000).  In 
contrast, a recent study of inflammatory pain (subcutaneous carrageenan injection) 
revealed a different pattern of Na+-channel expression in which NaV1.3, NaV1.7 and 
NaV1.8 are selectively increased in small (<30μm) DRG neurons(Black, Liu et al. 2004).  
Electrophysiological assessments of sensory neurons have demonstrated altered action 
potential characteristics consistent with increased excitability, suggesting that modified 
expression of Na+-channels is a critical factor in hyperalgesia(Waxman, Cummins, Dib-
Hajj, and Black ,2000). The fact that administration of nerve growth factor (NGF) and 
glial-derived neurotrophic factor (GDNF) prevent hyperexcitability following nerve 
injury supports the hypothesis that altered channel expression is due to the failure of 
retrograde axonal transport of growth factors in damaged axons (Waxman, Cummins, 
Dib-Hajj, and Black ,2000;Leffler, Cummins et al. 2002). On the other hand, phenotypic 
changes in Na+-channel expression in inflammation may be due to elevated levels of 
NGF and other mediators released near inflamed nerve terminals(Black, Liu, Tanaka, 
Cummins, and Waxman ,2004;Frostick, Yin et al. 1998). A particularly relevant 
observation is that concurrent treatment with ibuprofen reduces inflammation-induced 
hyperalgesia as well as expression of NaV1.7 and NaV1.8(Gould, III, England et al. 2004).  
 
Donnelly and his colleagues explored the properties of voltage-sensitive Na+-currents in 
rat PG neurons which were back-labeled with a fluorescent dye applied to the carotid 
body(Cummins, Dib-Hajj et al. 2002). These authors reported that in ~80% of 
chemoafferent neurons >95% of the Na+-current was TTX-sensitive. Moreover, detailed 
analysis of current kinetics indicated the involvement of NaV1.7, along with NaV1.1 
and/or NaV1.6. These findings concur with a previous study showing that spontaneous 
activity generated in the terminals of rat carotid chemoreceptors is highly sensitive to 
TTX(Donnelly, Panisello et al. 1998).  
 
We recently initiated a preliminary study of the effect of CH on Na+-channel expression, 
and voltage-sensitive Na+-current in PG neurons. Consistent with reports that 
inflammation up-regulates NaV expression(Black, Liu, Tanaka, Cummins, and Waxman 
,2004), our immunocytochemical data shown in figure 6 demonstrate increased NaV 
staining intensity in PG neurons following 3 days of CH. These images were produced 
using a pan-specific antibody which recognizes all α-isoforms. Indication of specific NaV 
involvement is suggested in figure 7, which shows that 3 days of CH elicits an 
approximately 16-fold increase in expression of NaV1.7 transcript in the PG. Note that the 
transcript level was normal following 1 day of hypoxia, consistent with the possibility 
that increased expression involves retrograde signaling from the carotid body.  
 
In a 2004 study, Black, et al., demonstrated that hyperalgesia elicited by peripheral 
inflammation is correlated with increased Na+-current density in small diameter (≤ 25 
μm) DRG neurons(Black, Liu, Tanaka, Cummins, and Waxman ,2004). In similarly sized 
PG neurons we have found that Na+-currents are likewise increased following 4-5 days of 
CH. The family of membrane current traces shown in figure 8 were obtained using a 
holding potential of -120mV, and currents were evoked by 20 msec voltage steps (5mV) 
to potentials between -80mV and +40mV. Measurement of peak current amplitude 
indicates a 50% increase following CH (fig. 8, lower panel). In view of these findings it 
is intriguing that Waxman and his colleagues proposed that the unique kinetic properties 
of NaV1.7 make it a candidate for activation in response to the slow depolarization 
elicited by chemical, mechanical and/or thermal stimuli in sensory nerve 
terminals(Cummins, Howe et al. 1998;Cummins, Sheets, and Waxman ,2007). Moreover, 
selective knock-out of NaV1.7 in a subpopulation of small diameter neurons resulted in 
decreased thermal and mechanical hypersensitivity induced by inflammation(Nassar, 
Stirling et al. 2004). Consequently, increased expression of this isoform may, in part, 
underlie the observed hyperexcitability in nociceptors, as well as chemoreceptors, 
following inflammation. A more complete understanding of the role of inflammation in 
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altered Na+-channel expression will come with an evaluation of the effect of anti-
inflammatory drugs on NaV transcript levels and Na+-currents in chemoafferent neurons. 
In addition, a role for Na+-currents may be further defined by examining the effects of 
CH on chemoreceptor adaptation in selected NaV gene-deleted animals. 
 
 
 
The Chemoafferent Pathway and Inflammation: Future Directions 
Our recent studies have expanded upon earlier work which demonstrated that oxygen-
sensitive type I cells in the carotid body express cytokine receptors, and that CH elicits 
cytokine expression in the organ(Shu, Wang et al. 2007;Wang, Wang et al. 2002;Wang, 
Zhang et al. 2006;Lam, Tipoe, Liong, and Fung ,2008;Fan, Zhang et al. 2009). The extent 
of neuroimmune involvement in CH was further elucidated by documenting immune cell 
invasion, and examining the effects of anti-inflammatory drugs on adaptation. These 
findings may have implications for the use of common anti-inflammatory agents in the 
treatment of COPD and chronic heart failure, in addition to their use at high altitude. 
 
Major unresolved issues remain for future investigations of inflammation-mediated 
chemoreceptor adaptation. At this writing virtually nothing is known about the cellular 
mechanisms which trigger immune cell invasion and the up-regulation of cytokines. 
Because of their exquisite sensitivity to hypoxia, it is likely that type I cells are involved 
in signaling the immune response. As noted earlier, type I cells are highly adaptive to 
CH; it is likely that following the initial immune response, cytokines and their receptors 
participate in altering the functional status of type I cells. In this regard, it is important to 
note that previous studies of type I cell adaptation have demonstrated the involvement of 
hypoxia inducible factor-1 (HIF-1), a transcription factor known to be up-regulated by 
cytokines in multiple cell types(Hellwig-Burgel, Stiehl et al. 2005). 
 
In addition, it appears that the full extent of adaptation involves significant changes in the 
functional status of primary chemoafferent neurons, particularly the expression of 
specific receptor molecules in nerve terminals. Moreover, animal models of chronic pain 
indicate that plasticity of the neuronal phenotype is influenced by local and retrograde 
signaling of neurotrophic factors produced in inflamed targets(Malin, Molliver et al. 
2006;Cummins, Sheets, and Waxman ,2007). Therefore, important regulatory 
mechanisms may be elucidated by investigating the production and dynamics of selected 
factors in the inflamed carotid body. Finally, it is well established that inflammation and 
neuropathy initiate complex changes within the spinal cord, including the up-regulation 
of inflammatory cytokines. The resulting central sensitization is critical for the full 
development of hyperalgesia and allodynia(Woolf ,2010). Thus the studies of Powell and 
his colleagues (in press, this issue Resp. Physiol. Neurobiol.), which show that central 
amplification of chemoreflex signaling following CH is blocked by ibuprofen, further 
implicate the global involvement of unique neuroimmune mechanisms in the control of 
breathing. 
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Figure 1. Immunofluorescence in rat carotid body of type I cell marker tyrosine 
hydroxylase (red, TH), and immune cell antigen ED1 (green). A: normal; B, C, and D:1, 
3 and 7 days of CH, respectively. Scale bar: 50 um. (From Liu, He et al. 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure 2. Time course of  chronic hypoxia (CH)-induced inflammatory cytokine, and 
tyrosine hydroxylase (TH) gene expression in rat carotid body. Quantitative PCR data 
normalized to 18sRNA and expressed relative to mRNA levels in normal tissue. MCP-1: 
monocyte chemoattractant protein-1; IL6: interleukin-6; IL 1b: interleukin-1β; TNFa: 
tumor necrosis factor-α. *, **, and *** indicate p<0.05, 0.01 and 0.001, respectively. CH: 
exposure at 380 Torr for time indicated. (From Liu, He et al. 2009) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Left panel: Carotid sinus nerve activity evoked by a standard hypoxic stimulus  
(indicated by separate trace of bath PO2) in normal (N) vs. 8-10 day chronic hypoxia 
(CH) preparations. CH elicits a robust increase in hypoxic sensitivity and basal resting 
activity; however, note that hypersensitivity to hypoxic challenge is absent in CH animals 
concurrently treated with dexamethasone (Dex; 0.1 mg/kg/day), or ibuprofen (Ib; 4 
mg/kg/day). Right panel: Summary data (averaged evoked impulses/sec) from 4 or 6 
preparations in each group: drug free (upper) or concurrently treated with either 
dexamethasone or ibuprofen (middle and lower). *** indicates p<0,001 vs. normal. 
(From Liu, He et al. 2009) 
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Figure 4. Effect of ibuprofen, A, (ib; 4 mg/kg/day) or dexamethasone, B, (DX; 0.1 
mg/kg/day)  on 7 day CH-induced gene expression of tyrosine hydroxylase and cytokines 
in rat carotid body. Abbreviations as in figure 2. *, **, and *** indicate p< 0.05, 0.01, 
and 0.001, respectively, vs. normal; +, ++, and +++, p< 0.05, 0.01, and 0.001, 
respectively, vs. 7 days CH. (Adapted from Liu, He et al. 2009) 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Effect of anti-inflammatory drugs on CH-induced immune cell activity in rat 
carotid body. Green cells are immunostained for CD45, a universal leukocyte marker; red 
indicates TH. (A) Normal carotid body contains a few immune cells that weakly express 
CD45. Following 3 days of CH  (D) the tissue contains numerous cells which express 
higher levels of CD45. In normoxic carotid bodies from animals treated with 
dexamethasone (0.1 mg/kg/day; B) or ibuprofen (4 mg/kg/day; C) few or no detectable 
CD45+ immune cells are visible. Likewise, in CH animals treated with dexamethasone 
(E) or ibuprofen (F), CD45+ cells are virtually absent. Notice that TH fluorescence is 
increased in animals treated with dexamethasone. (From Liu, He et al. 2009) 
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Figure 6. Immunofluorescent assessment of Na+-channel expression in petrosal (IXth 
nerve) ganglion from normal (A) and 3 day CH rats. Formaldehyde-fixed frozen sections 
were immunostained with pan-specific antibody (Sigma, St. Louis, MO; product #S6936) 
which recognizes all α-NaV subunits. Scale bar, 30 um. 
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Figure 7. Time course of  chronic hypoxia (CH)-induced up-regulation of NaV1.7 α-
subunit of voltage gated Na+-channel. Quantitative PCR data normalized to 18sRNA and 
expressed relative to mRNA levels in normal tissue. *** indicates p< 0.001. CH: 
exposure at 380 Torr for time indicated.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 8. Upper panel: Whole-cell patch clamp recording of family of Na+-currents in  
petrosal ganglion neurons (≤ 25 μm) harvested from normal (left) and 5 day CH (380 
Torr; right) adult male rats. Currents were evoked from a holding potential of -120mV by 
20 msec steps (5mV) to potentials between -80mV and +40mV. Lower panel: Plot of 
peak current amplitude indicates a 50% increase following CH. 
  
